Makers of dietary supplements push the FDA to allow peptides and other new ingredients

March 29, 2026 - 18:52

The dietary supplement industry is actively urging the U.S. Food and Drug Administration to modernize its regulatory approach to allow novel ingredients, including peptides and other compounds, into products sold over the counter. This push centers on the current regulatory framework, which many manufacturers argue is outdated and stifles innovation.

Industry representatives contend that the existing rules, largely unchanged for decades, prevent consumers from accessing potentially beneficial new dietary ingredients developed through advanced scientific research. They are calling for clearer, more efficient pathways for ingredient approval that still ensure rigorous safety standards. The goal is to establish a more transparent and predictable process for introducing new components into the market.

Proponents assert that updating these regulations would align the U.S. market with global standards and foster the development of next-generation wellness products. They emphasize that consumer safety remains paramount, advocating for a system that evaluates scientific evidence without unnecessary delay. This ongoing dialogue highlights the tension between rapid industry innovation and the FDA's mandate to protect public health, setting the stage for a critical examination of supplement oversight.